Intermediates of Rosuvastatin Calcium | No. | Item | Structural Formula | CAS No. |
|---|---|---|---|---|
| D5 | tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate |  | 154026-95-6 | |
| D6 | (4R-Cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester |  | 124655-09-0 | |
| D7 | tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate |  | 124752-23-4 | |
| Z8.2 | [[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide |  | 885477-83-8 | |
| D8 | tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate |  | 289042-12-2 | |
| D9(tert-butyl ester) | tert-Butyl (6E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[(methanesulfonyl)methylamino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid tert-butyl ester |  | 355806-00-7 | |
| Rosuvastatin Calcium | Rosuvastatin Calcium |  | 147098-20-2 | |
Intermediates of Pitavastatin Calcium | 1 | (4R,6S)-6-[(1E)-2-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid tert-butyl ester |  | 147489-06-3 |
| 2 | Pitavastatin Calcium |  | 147526-32-7 | |
Intermediates of Rivaroxaban | 1 | 4-(4-Aminophenyl)morpholin-3-one |  | 438056-69-0 |
| 2 | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one |  | 446292-10-0 | |
| 3 | Rivaroxaban |  | 366789-02-8 | |
Intermediates of Rivaroxaban | 1 | 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone |  | 1267610-26-3 |
| 2 | 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone |  | 545445-44-1 | |
| 3 | 6003（利伐沙班） |  | 503612-47-3 | |
Intermediates of Ticagrelor | 1 | 4,6-Dichloro-2-(propylthio)pyrimidin-5-amine |  | 145783-15-9 |
| 2 | (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol |  | 155899-66-4 | |
| 3 | N-[(3aS,4R,6S,6aR)-Tetrahydro-6-(2-hydroxyethoxy)-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamic acid phenylmethyl ester |  | 274693-54-8 | |
| 4 | 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate |  | 376608-65-0 | |
| 5 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid |  | 220352-36-3 | |
| 6 | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate |  | 376608-71-8 | |
| 7 | Ticagrelor |  | 274693-27-5 | |
| Intermediates of Brivaracetam | 1 | (4R)-4-Propylpyrrolidin-2-one |  | 930123-37-8 |
| 2 | Brivaracetam |  | 357336-20-0 | |
| Intermediates of Empaglifozin | 1 | Empaglifozin |  | 864070-44-0 |
Intermediates of Sitagliptin | 1 | 2-(2,4,5-trifluorophenyl)acetic acid |  | 209995-38-0 |
| 2 | Sitagliptin |  | 654671-77-9 | |
Intermediates of Quinolones | 1 | intermediate of Ciprofloxacin |  | 86393-33-1 |
| 2 | Levofloxacin carboxylic acid |  | 100986-89-8 |
投資者關系
浙公網安備33062402000304（浙）-非經營性- 2020-0041
中文
English
